BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17215638)

  • 21. Use of lipid-lowering medications at discharge in patients with acute myocardial infarction: data from the National Registry of Myocardial Infarction 3.
    Fonarow GC; French WJ; Parsons LS; Sun H; Malmgren JA
    Circulation; 2001 Jan; 103(1):38-44. PubMed ID: 11136683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction.
    Shore S; Jones PG; Maddox TM; Bradley SM; Stolker JM; Arnold SV; Parashar S; Peterson P; Bhatt DL; Spertus J; Ho PM
    Heart; 2015 May; 101(10):800-7. PubMed ID: 25801001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of the 2013 American College of Cardiology/American Heart Association cholesterol guidelines on the prescription of high-intensity statins in patients hospitalized for acute coronary syndrome or stroke.
    Valentino M; Al Danaf J; Panakos A; Ragupathi L; Duffy D; Whellan D
    Am Heart J; 2016 Nov; 181():130-136. PubMed ID: 27823684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Audit-based education to reduce suboptimal management of cholesterol in primary care: a before and after study.
    de Lusignan S; Belsey J; Hague N; Dhoul N; van Vlymen J
    J Public Health (Oxf); 2006 Dec; 28(4):361-9. PubMed ID: 17038329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinants of appropriate lipid management in patients with ischaemic heart disease. Cracovian Program for Secondary Prevention of Ischaemic Heart Disease.
    Kawecka-Jaszcz K; Jankowski P; Pajak A
    Int J Cardiol; 2003 Sep; 91(1):15-23. PubMed ID: 12957725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sociodemographic and diagnostic characteristics of prescribing a second-line lipid-lowering medication: ezetimibe used as initial medication, switch from statins, or add-on medication.
    Wallach-Kildemoes H; Hansen EH
    Eur J Clin Pharmacol; 2015 Oct; 71(10):1245-54. PubMed ID: 26227068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of new coronary events and new atherothrombotic brain infarction in older persons with diabetes mellitus, prior myocardial infarction, and serum low-density lipoprotein cholesterol >/=125 mg/dl treated with statins.
    Aronow WS; Ahn C; Gutstein H
    J Gerontol A Biol Sci Med Sci; 2002 Nov; 57(11):M747-50. PubMed ID: 12403804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical determinants and treatment gaps in familial hypercholesterolemia: Data from a multi-ethnic regional health service.
    Zafrir B; Jubran A; Lavie G; Halon DA; Flugelman MY; Shapira C
    Eur J Prev Cardiol; 2017 May; 24(8):867-875. PubMed ID: 28186442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients with Hypercholesterolemia or Low High-Density Lipoprotein Cholesterol.
    Ballantyne CM; Shah S; Kher U; Hunter JA; Gill GG; Cressman MD; Ashraf TB; Johnson-Levonas AO; Mitchel YB
    Am J Cardiol; 2017 Feb; 119(3):388-396. PubMed ID: 27956003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Underutilization of measurement of serum low-density lipoprotein cholesterol levels and of lipid-lowering therapy in older patients with manifest atherosclerotic disease.
    Mendelson G; Aronow WS
    J Am Geriatr Soc; 1998 Sep; 46(9):1128-31. PubMed ID: 9736107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
    Avellone G; Di Garbo V; Guarnotta V; Scaglione R; Parrinello G; Purpura L; Torres D; Campisi D
    Int Angiol; 2010 Dec; 29(6):514-24. PubMed ID: 21173733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals.
    Waters DD; Brotons C; Chiang CW; Ferrières J; Foody J; Jukema JW; Santos RD; Verdejo J; Messig M; McPherson R; Seung KB; Tarasenko L;
    Circulation; 2009 Jul; 120(1):28-34. PubMed ID: 19546386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modifiable factors associated with failure to attain low-density lipoprotein cholesterol goal at 6 months after acute myocardial infarction.
    Martin SS; Gosch K; Kulkarni KR; Spertus JA; Mathews R; Ho PM; Maddox TM; Newby LK; Alexander KP; Wang TY
    Am Heart J; 2013 Jan; 165(1):26-33.e3. PubMed ID: 23237130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of Severe and Moderate Hypercholesterolemia in Young Women and Men.
    Newton SL; Hoffmann AP; Yu Z; Haidermota S; Natarajan P; Honigberg MC
    JAMA Cardiol; 2022 Feb; 7(2):227-230. PubMed ID: 34780599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimizing lipid management in patients with acute coronary syndromes.
    Pepine CJ
    Am J Cardiol; 2003 Feb; 91(4A):30B-35B. PubMed ID: 12615296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac medication prescribing and adherence after acute myocardial infarction in Chinese and South Asian Canadian patients.
    Lai EJ; Grubisic M; Palepu A; Quan H; King KM; Khan NA
    BMC Cardiovasc Disord; 2011 Sep; 11():56. PubMed ID: 21923931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of atorvastatin on interventional therapy in patients with acute myocardial infarction.
    Wang K; Chen L; Liu L; Cui Y; Zhang X; Jiang J
    Minerva Med; 2019 Apr; 110(2):101-106. PubMed ID: 29696937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of patients discharged from pharmacy-managed cardiovascular disease management.
    Olson KL; Delate T; Rasmussen J; Humphries TL; Merenich JA;
    Am J Manag Care; 2009 Aug; 15(8):497-503. PubMed ID: 19670953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statin initiation following coronary artery bypass grafting: outcome of a hospital discharge protocol.
    Khanderia U; Townsend KA; Eagle K; Prager R
    Chest; 2005 Feb; 127(2):455-63. PubMed ID: 15705982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.